View Clinical Trial (Medical Research Study)
A Randomized, Double-Blind Study of the Effects of Fenretinide Administered in Subjects With Obesity - NCT00546455-92161B(Clinical Trial 188136)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
San Diego |
|
State:
|
|
CA |
| Zip Code: |
|
92161 |
| Conditions: |
|
Obesity - Insulin Resistance |
| Purpose: |
|
Many metabolic complications of obesity are a consequence of abnormal responses of the
liver, muscle, and fat to insulin actions. Fenretinide may improve the effects of insulin,
preventing metabolic complications.
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- BMI >30
Exclusion Criteria:
- Diabetes Requiring Medication
- Poorly Controlled Co-Morbidities |
|
|
|
|
|
|
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
July 2, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|